185 related articles for article (PubMed ID: 20885070)
1. Ten-year evaluation of homogeneous low-density lipoprotein cholesterol methods developed by Japanese manufacturers. Application of the Centers for Disease Control and Prevention/Cholesterol Reference Method Laboratory Network lipid standardization protocol.
Nakamura M; Koyama I; Iso H; Sato S; Okazaki M; Kayamori Y; Kiyama M; Kitamura A; Shimamoto T; Ishikawa Y
J Atheroscler Thromb; 2010 Dec; 17(12):1275-81. PubMed ID: 20885070
[TBL] [Abstract][Full Text] [Related]
2. Measurement performance of reagent manufacturers by Centers for Disease Control and Prevention/Cholesterol Reference Method Laboratory Network lipid standardization specified for metabolic syndrome-focused health checkups program in Japan.
Nakamura M; Koyama I; Iso H; Sato S; Okazaki M; Kiyama M; Shimamoto T; Konishi M
J Atheroscler Thromb; 2009; 16(6):756-63. PubMed ID: 19763016
[TBL] [Abstract][Full Text] [Related]
3. Total cholesterol performance of Abell-Levy-Brodie-Kendall reference measurement procedure: Certification of Japanese in-vitro diagnostic assay manufacturers through CDC's Cholesterol Reference Method Laboratory Network.
Nakamura M; Iso H; Kitamura A; Imano H; Kiyama M; Yokoyama S; Kayamori Y; Koyama I; Nishimura K; Nakai M; Dasti M; Vesper HW; Teramoto T; Miyamoto Y
Clin Chim Acta; 2015 May; 445():127-32. PubMed ID: 25818239
[TBL] [Abstract][Full Text] [Related]
4. The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements.
Myers GL; Cooper GR; Winn CL; Smith SJ
Clin Lab Med; 1989 Mar; 9(1):105-35. PubMed ID: 2538292
[TBL] [Abstract][Full Text] [Related]
5. Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the Postprandial and Fasting State.
Miida T; Nishimura K; Hirayama S; Miyamoto Y; Nakamura M; Masuda D; Yamashita S; Ushiyama M; Komori T; Fujita N; Yokoyama S; Teramoto T
J Atheroscler Thromb; 2017 Jun; 24(6):583-599. PubMed ID: 28321014
[TBL] [Abstract][Full Text] [Related]
6. [Standardization of the methods of lipid determination according to WHO in the regional project of prevention of cardiovascular diseases in Friuli-Venezia Giulia].
Grafnetter D; Feruglio GA; Vanuzzo D
G Ital Cardiol; 1996 Mar; 26(3):287-97. PubMed ID: 8690184
[TBL] [Abstract][Full Text] [Related]
7. [Cholesterol controversy: cutoff point of low-density lipoprotein cholesterol level in Guidelines by Japan Atherosclerosis Society].
Inadera H; Hamazaki T
Nihon Eiseigaku Zasshi; 2010 Sep; 65(4):506-15. PubMed ID: 20885077
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
[TBL] [Abstract][Full Text] [Related]
9. LDL cholesterol performance of beta quantification reference measurement procedure.
Nakamura M; Kayamori Y; Iso H; Kitamura A; Kiyama M; Koyama I; Nishimura K; Nakai M; Noda H; Dasti M; Vesper HW; Miyamoto Y
Clin Chim Acta; 2014 Apr; 431():288-93. PubMed ID: 24589772
[TBL] [Abstract][Full Text] [Related]
10. Ten-year standardization of lipids and high-sensitivity C-reactive protein in a randomized controlled trial to assess the effects of statins on secondary stroke prevention: Japan Statin Treatment Against Recurrent Stroke.
Nakamura M; Fukukawa T; Kitagawa K; Nagai Y; Hosomi N; Minematsu K; Uchiyama S; Matsumoto M; Miyamoto Y;
Ann Clin Biochem; 2018 Jan; 55(1):128-135. PubMed ID: 28135841
[TBL] [Abstract][Full Text] [Related]
11. Relationship between Non-High-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol in the General Population.
Kuwabara K; Harada S; Sugiyama D; Kurihara A; Kubota Y; Higashiyama A; Hirata T; Nishida Y; Kawasaki M; Takebayashi T; Okamura T
J Atheroscler Thromb; 2016; 23(4):477-90. PubMed ID: 26961218
[TBL] [Abstract][Full Text] [Related]
12. [Status of cholesterol goal attainment for the primary and secondary prevention of atherosclerotic cardiovascular disease in dyslipidemia patients receiving lipid-lowering therapy: DYSIS-China subgroup analysis].
Li Y; Zhao SP; Ye P; Yan XW; Mu YM; Wei YD; Hu DY;
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Aug; 44(8):665-70. PubMed ID: 27545124
[TBL] [Abstract][Full Text] [Related]
13. Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events.
Elshazly MB; Nicholls SJ; Nissen SE; St John J; Martin SS; Jones SR; Quispe R; Stegman B; Kapadia SR; Tuzcu EM; Puri R
Am J Cardiol; 2016 Sep; 118(5):647-55. PubMed ID: 27392507
[TBL] [Abstract][Full Text] [Related]
14. Comparison between the triglycerides standardization of routine methods used in Japan and the chromotropic acid reference measurement procedure used by the CDC Lipid Standardization Programme.
Nakamura M; Iso H; Kitamura A; Imano H; Noda H; Kiyama M; Sato S; Yamagishi K; Nishimura K; Nakai M; Vesper HW; Teramoto T; Miyamoto Y
Ann Clin Biochem; 2016 Nov; 53(6):632-639. PubMed ID: 26680645
[TBL] [Abstract][Full Text] [Related]
15. Measurement of cholesterol and other lipoprotein constituents in the clinical laboratory.
Warnick GR
Clin Chem Lab Med; 2000 Apr; 38(4):287-300. PubMed ID: 10928647
[TBL] [Abstract][Full Text] [Related]
16. Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US Cholesterol Reference Method Laboratory Network.
Nakamura M; Sato S; Shimamoto T
J Atheroscler Thromb; 2003; 10(3):145-53. PubMed ID: 14564083
[TBL] [Abstract][Full Text] [Related]
17. [Multicenter evaluation of four homogenous LDL-cholesterol assays].
Bayer P; Veinberg F; Couderc R; Cherfils C; Cambillau M; Cosson C; Fradin S; Gillery P; Steinmetz J; Legrand A; Egloff M; Beucler I
Ann Biol Clin (Paris); 2005; 63(1):27-41. PubMed ID: 15689310
[TBL] [Abstract][Full Text] [Related]
18. [Current Status and Future of Lipid Examination in the Prevention and Clinical Treatment of Atherosclerotic Diseases--Chairmen's Introductory Remarks].
Yoshida H; Miida T
Rinsho Byori; 2014 Sep; 62(9):876-7. PubMed ID: 27526532
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
